BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12215688)

  • 1. Effect of St. John's Wort extract on intestinal expression of cytochrome P4501A2: studies in LS180 cells.
    Karyekar CS; Eddington ND; Dowling TC
    J Postgrad Med; 2002; 48(2):97-100. PubMed ID: 12215688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol.
    Schwarz UI; Hanso H; Oertel R; Miehlke S; Kuhlisch E; Glaeser H; Hitzl M; Dresser GK; Kim RB; Kirch W
    Clin Pharmacol Ther; 2007 May; 81(5):669-78. PubMed ID: 17392718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of St. John's wort extract on indinavir pharmacokinetics in rats: differentiation of intestinal and hepatic impacts.
    Ho YF; Huang DK; Hsueh WC; Lai MY; Yu HY; Tsai TH
    Life Sci; 2009 Aug; 85(7-8):296-302. PubMed ID: 19559714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.
    Dresser GK; Schwarz UI; Wilkinson GR; Kim RB
    Clin Pharmacol Ther; 2003 Jan; 73(1):41-50. PubMed ID: 12545142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?
    Beattie PE; Dawe RS; Traynor NJ; Woods JA; Ferguson J; Ibbotson SH
    Br J Dermatol; 2005 Dec; 153(6):1187-91. PubMed ID: 16307656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort extract induces CYP3A and CYP2E1 in the Swiss Webster mouse.
    Bray BJ; Perry NB; Menkes DB; Rosengren RJ
    Toxicol Sci; 2002 Mar; 66(1):27-33. PubMed ID: 11861970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study.
    Shibayama Y; Ikeda R; Motoya T; Yamada K
    Food Chem Toxicol; 2004 Jun; 42(6):995-1002. PubMed ID: 15110109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
    Matheny CJ; Ali RY; Yang X; Pollack GM
    Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. St John's wort modulation and developmental expression of multidrug transporters in the rat.
    Garrovo C; Rosati A; Bartoli F; Decorti G
    Phytother Res; 2006 Jun; 20(6):468-73. PubMed ID: 16619352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect.
    Hatanaka J; Shinme Y; Kuriyama K; Uchida A; Kou K; Uchida S; Yamada S; Onoue S
    Drug Metab Pharmacokinet; 2011; 26(6):551-8. PubMed ID: 21914965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CYP1A by green tea extract in human intestinal cell lines.
    Netsch MI; Gutmann H; Schmidlin CB; Aydogan C; Drewe J
    Planta Med; 2006 May; 72(6):514-20. PubMed ID: 16773535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of St. John's wort extract and single constituents on stress-induced hyperthermia in mice.
    Grundmann O; Kelber O; Butterweck V
    Planta Med; 2006 Dec; 72(15):1366-71. PubMed ID: 17051457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver.
    Dostalek M; Pistovcakova J; Jurica J; Tomandl J; Linhart I; Sulcová A; Hadasova E
    Life Sci; 2005 Dec; 78(3):239-44. PubMed ID: 16125735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
    Hellum BH; Hu Z; Nilsen OG
    Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):23-30. PubMed ID: 17214607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.